| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-19 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-10 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.37 | 6e-09 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.4 | 4e-08 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.32 | 3e-06 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |